2022
DOI: 10.36416/1806-3756/e20220103
|View full text |Cite
|
Sign up to set email alerts
|

EBUS-TBNA versus mediastinoscopy for mediastinal staging of lung cancer: a cost-minimization analysis

Abstract: Objective: To assess cost differences between EBUS-TBNA and mediastinoscopy for mediastinal staging of non-small cell lung cancer (NSCLC). Methods: This was an economic evaluation study with a cost-minimization analysis. We used a decision analysis software program to construct a decision tree model to compare the downstream costs of mediastinoscopy, EBUS-TBNA without surgical confirmation of negative results, and EBUS-TBNA with surgical confirmation of negative results for the mediastinal staging of NSCLC. Th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 22 publications
0
1
0
Order By: Relevance
“…Although the least costly technique is an EBUS- transbronchial needle aspiration (TBNA), there is a group of cases that will require an added diagnostic technique (e.g., the performance of MDS, after EBUS-TBNA in selected patients) ( 27 , 28 ). These studies and protocols are developed to identify patients in developed countries, hence, requiring other cost-effectiveness studies in underdeveloped countries to appreciate the economic burden and the obstacles to reach life-threatening diagnoses (e.g., the utility of these techniques to rule out lung cancer-related lymphadenopathy in regions of high TB incidence) ( 29 , 30 ). he most common presenting diagnoses of IMA in our study were Sarcoidosis and lymphoma (51% of the cases) which are tissue-based diagnoses and not cytology-based, deeming the FNAC techniques devalued, diagnostically.…”
Section: Discussionmentioning
confidence: 99%
“…Although the least costly technique is an EBUS- transbronchial needle aspiration (TBNA), there is a group of cases that will require an added diagnostic technique (e.g., the performance of MDS, after EBUS-TBNA in selected patients) ( 27 , 28 ). These studies and protocols are developed to identify patients in developed countries, hence, requiring other cost-effectiveness studies in underdeveloped countries to appreciate the economic burden and the obstacles to reach life-threatening diagnoses (e.g., the utility of these techniques to rule out lung cancer-related lymphadenopathy in regions of high TB incidence) ( 29 , 30 ). he most common presenting diagnoses of IMA in our study were Sarcoidosis and lymphoma (51% of the cases) which are tissue-based diagnoses and not cytology-based, deeming the FNAC techniques devalued, diagnostically.…”
Section: Discussionmentioning
confidence: 99%